C. Serruya

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

W. Foulkes, E. Warner, W. Meschino, 1999, Journal of the National Cancer Institute.

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population

J. Ragoussis, C. Greenwood, A. Mes-Masson, 2022, Cancers.

Is hereditary site-specific ovarian cancer a distinct genetic condition?

W. Foulkes, P. Tonin, S. Narod, 1998, American journal of medical genetics.

A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene

Trevor J Pugh, J. Ragoussis, C. Greenwood, 2021, Genome medicine.

The genetic analysis of a founder Northern American population of European descent identifies FANCI as a candidate familial ovarian cancer risk gene

J. Ragoussis, C. Greenwood, A. Mes-Masson, 2020, medRxiv.

Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells

W. Foulkes, G. Batist, R. Sladek, 2002, Oncogene.

Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene

Trevor J Pugh, J. Ragoussis, C. Greenwood, 2023, Genes.

Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants

J. Ragoussis, A. Mes-Masson, W. Foulkes, 2022, Genes.

False family history of breast cancer in the family cancer clinic.

D. Evans, S. Narod, C. Serruya, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases

Trevor J Pugh, J. Ragoussis, C. Greenwood, 2023, Frontiers in Oncology.

Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer

J. Ragoussis, A. Mes-Masson, D. Provencher, 2023, medRxiv.

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

W. Foulkes, E. Warner, W. Meschino, 1999, Journal of the National Cancer Institute.